Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
479 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06942507 | Zanubrutinib Combined With BR in the First-line Treatment of Waldenström's Macroglobulinemia(BRZ-WM) | not yet recruiting | N/A | 104 | Peking Union Medical College HospitalOTHER | 1 | Apr 30, 2025 | clinicaltrials |
| NCT06931145 | Benmelstobart, Anlotinib and Chemotherapy as First-line Treatment for Extensive-stage Small-cell Lung Cancer | not yet recruiting | Phase 4 | 50 | Peking Union Medical College HospitalOTHER | 1 | Apr 23, 2025 |
| clinicaltrials |
| NCT06898437 | Study of 177Lu-LNC1004 Injection in FAP-positive Radioiodine-refractory Differentiated Thyroid Cancer | recruiting | Early Phase 1 | 20 | Peking Union Medical College HospitalOTHER | 1 | Apr 15, 2025 | clinicaltrials |
| NCT06927232 | AZA+Lus VS AZA Monotherapy in HR-MDS | not yet recruiting | Phase 3 | 86 | Peking Union Medical College HospitalOTHER | 0 | Apr 15, 2025 | clinicaltrials |
| NCT06908291 | Photoacoustic/Ultrasound Imaging for Breast Nodule Diagnosis, Molecular Classification, and Neoadjuvant Chemotherapy Response Evaluation | recruiting | N/A | 500 | Peking Union Medical College HospitalOTHER | 1 | Apr 3, 2025 | clinicaltrials |
| NCT06056362 | Comparison of Al18F-NOTA-LM3 With 68Ga-DOTATATE and 68Ga-NODAGA-LM3 PET/CT in Patients With Well-differentiated Neuroendocrine Tumors | recruiting | Phase 1 / Phase 2 | 80 | Peking Union Medical College HospitalOTHER | 1 | Apr 2, 2025 | clinicaltrials |
| NCT06907602 | Optimizing Neoadjuvant Treatment Regimens for Locally Advanced Esophageal Squamous Cell Carcinoma(ONTRESCC) | recruiting | Phase 2 / Phase 3 | 120 | Peking Union Medical College HospitalOTHER | 1 | Apr 2, 2025 | clinicaltrials |
| NCT06641635 | Moderated Hypofractionated Online Adaptive Radiotherapy in Cervical Cancer | recruiting | Phase 3 | 440 | Peking Union Medical College HospitalOTHER | 1 | Mar 18, 2025 | clinicaltrials |
| NCT06866392 | Study on Novel Strategies for Cervical Cancer Screening Using Photoelectric Detection and Epigenetic Procotol(CC-AZ) | not yet recruiting | — | 4,200 | Peking Union Medical College HospitalOTHER | 0 | Mar 10, 2025 | clinicaltrials |
| NCT06867146 | MRD in PAAD Adjuvant Therapy | active not recruiting | N/A | 60 | Peking Union Medical College HospitalOTHER | 1 | Mar 10, 2025 | clinicaltrials |
| NCT06864572 | [68Ga]Ga-P17-079 in the Diagnosis and Treatment of Metastatic Prostate Cancer | enrolling by invitation | Early Phase 1 | 40 | Peking Union Medical College HospitalOTHER | 1 | Mar 7, 2025 | clinicaltrials |
| NCT06773819 | A Study on the Pathogenesis and Determinants of Intravenous Leiomyomatosis | not yet recruiting | — | 30 | Peking Union Medical College HospitalOTHER | 0 | Feb 28, 2025 | clinicaltrials |
| NCT06824883 | Sintilimab, Pegaspargase Plus GemOx for Untreated Extranodal NK/T-Cell Lymphoma | recruiting | Phase 2 | 49 | Peking Union Medical College HospitalOTHER | 1 | Feb 13, 2025 | clinicaltrials |
| NCT06823817 | Quality Control of Colposcopy Application(QCCA) | completed | — | 10,000 | Peking Union Medical College HospitalOTHER | 0 | Feb 12, 2025 | clinicaltrials |
| NCT06823830 | Clinical、metabolomics and the Study of Intestinal Flora of Jinfeng Pills in the Treatment of Polycystic Ovary Syndrome | unknown | Phase 4 | 105 | Peking Union Medical College HospitalOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT06028672 | Toripalimab Plus Actinomycin-D as Fist-Line Treatment for GTN With FIGO Score 5-6(TA56) | recruiting | N/A | 40 | Peking Union Medical College HospitalOTHER | 1 | Feb 6, 2025 | clinicaltrials |
| NCT06792149 | Prediction of Drug Response in Gastric Cancer Based on 3D Bioprinting | unknown | — | 60 | Peking Union Medical College HospitalOTHER | 1 | Jan 24, 2025 | clinicaltrials |
| NCT06353061 | Chemoradiotherapy With or Without Metformin in Locally Advanced Cervical Cancer | unknown | Phase 2 | 51 | Peking Union Medical College HospitalOTHER | 1 | Jan 14, 2025 | clinicaltrials |
| NCT06773832 | AI in Predicting Polyp Pathology and Endoscopic Classification | recruiting | — | 400 | Peking Union Medical College HospitalOTHER | 1 | Jan 14, 2025 | clinicaltrials |
| NCT06774209 | Multimodal PET Imaging in the Diagnosis and Treatment of Pelvic Tumors | recruiting | N/A | 30 | Peking Union Medical College HospitalOTHER | 1 | Jan 14, 2025 | clinicaltrials |
| NCT06771154 | Adebrelimab Plus Carboplatin/Paclitaxel Followed by Adebelizumab with or Without Apatinib in the Treatment of Advanced Recurrent/Metastatic Endometrial Cancer (A-CAPE): a Multicenter, Randomized, Controlled, Open-Label Clinical Trial(A-CAPE) | not yet recruiting | Phase 2 | 140 | Peking Union Medical College HospitalOTHER | 1 | Jan 13, 2025 | clinicaltrials |
| NCT06020755 | Toripalimab Plus Actinomycin-D As Fist-Line Treatment for GTN with FIGO Score 7(TA7) | recruiting | Phase 2 | 17 | Peking Union Medical College HospitalOTHER | 1 | Dec 31, 2024 | clinicaltrials |
| NCT06752408 | Aumolertinib Versus Osimertinib As First-line Therapy for Patients with EGFR Mutated Locally Advanced or Metastatic Non-small-cell Lung Cancer(ANOTHER) | not yet recruiting | Phase 2 | 316 | Peking Union Medical College HospitalOTHER | 1 | Dec 30, 2024 | clinicaltrials |
| NCT06750159 | The Use of AKR1B10 for Monitoring Postoperative Recurrence of Hepatocellular Carcinoma | not yet recruiting | — | 400 | Peking Union Medical College HospitalOTHER | 0 | Dec 27, 2024 | clinicaltrials |
| NCT05601505 | Circulating Tumor DNA-guided Neoadjuvant Treatment Strategy for Locally Advanced Rectal Cancer(CINTS-R) | recruiting | Phase 2 | 470 | Peking Union Medical College HospitalOTHER | 1 | Dec 24, 2024 | clinicaltrials |
| NCT06649838 | Customized Circulating Tumor DNA Testing for Cervical Cancer Recurrence Surveillance and Treatment Decisions | not yet recruiting | — | 60 | Peking Union Medical College HospitalOTHER | 0 | Dec 19, 2024 | clinicaltrials |
| NCT06739265 | Golidocitinib Plus CHOP in Newly Diagnosed PTCL | recruiting | Phase 1 / Phase 2 | 68 | Peking Union Medical College HospitalOTHER | 1 | Dec 18, 2024 | clinicaltrials |
| NCT06741046 | RT for Cervical Adenocarcinoma/adenosquamous Carcinoma | active not recruiting | — | 400 | Peking Union Medical College HospitalOTHER | 1 | Dec 18, 2024 | clinicaltrials |
| NCT06250244 | 177Lu-LNC1011 in Patients with Metastatic Castration-resistant Prostate Cancer | unknown | Phase 1 / Phase 2 | 12 | Peking Union Medical College HospitalOTHER | 1 | Dec 11, 2024 | clinicaltrials |
| NCT06362304 | 99mTc-CNDG SPECT/CT in Brain Tumors | recruiting | N/A | 30 | Peking Union Medical College HospitalOTHER | 1 | Nov 25, 2024 | clinicaltrials |
| NCT06698783 | Practical Application and Evaluation of Fortimel in Oncology Patients | unknown | N/A | 2,000 | Peking Union Medical College HospitalOTHER | 1 | Nov 21, 2024 | clinicaltrials |
| NCT06388031 | ICI Rechallenge for Advanced NSCLC With Long-Term Response to First-Line ICI | recruiting | Phase 2 | 27 | Peking Union Medical College HospitalOTHER | 1 | Nov 7, 2024 | clinicaltrials |
| NCT06674343 | Furmonertinib 160mg as First-line Treatment in Locally Advanced or Metastatic NSCLC With EGFR Classical Mutations | recruiting | Phase 3 | 144 | Peking Union Medical College HospitalOTHER | 1 | Nov 5, 2024 | clinicaltrials |
| NCT05424692 | Drug Sensitivity Detection of Micro Tumor (PTC) to Guide Postoperative Adjuvant Treatment Strategy of Colorectal Cancer | recruiting | N/A | 200 | Peking Union Medical College HospitalOTHER | 1 | Nov 4, 2024 | clinicaltrials |
| NCT06669481 | Correlation Between Preoperative Images of PPGL and Intraoperative Hemodynamics | completed | — | 159 | Peking Union Medical College HospitalOTHER | 1 | Nov 1, 2024 | clinicaltrials |
| NCT06664970 | A Multicenter Study on the Treatment of MDS/MPN Overlap Syndrome With AZA or Rux Combined With Selinexor | enrolling by invitation | Phase 2 | 39 | Peking Union Medical College HospitalOTHER | 1 | Oct 30, 2024 | clinicaltrials |
| NCT06660628 | Large Segmentation Radiotherapy ± Deep Inspiration Breath Hold(DIBH) for Left Breast Cancer(DLLEB) | recruiting | N/A | 348 | Peking Union Medical College HospitalOTHER | 1 | Oct 28, 2024 | clinicaltrials |
| NCT06659237 | Fecal and Oral Microbiota Between Pancreatic Cancer and Benign/Low-grade Malignant Tumor Patients | completed | — | 121 | Peking Union Medical College HospitalOTHER | 1 | Oct 26, 2024 | clinicaltrials |
| NCT06653452 | Application of PET/MRI in the Evaluation of the Efficacy of Neoadjuvant Therapy for Locally Advanced Rectal Cancer | recruiting | N/A | 30 | Peking Union Medical College HospitalOTHER | 1 | Oct 22, 2024 | clinicaltrials |
| NCT06644677 | Third-Generation Nanopore HPV Integration Site for Precise Prediction of Cervical Cancer Prognosis | completed | — | 200 | Peking Union Medical College HospitalOTHER | 1 | Oct 16, 2024 | clinicaltrials |
| NCT06632873 | 177Lu-TATE-RGD in Patients With SSTR2 and Integrin αVβ3 Positive Tumors | recruiting | Early Phase 1 | 10 | Peking Union Medical College HospitalOTHER | 1 | Oct 15, 2024 | clinicaltrials |
| NCT06638034 | Diagnosis of Metastatic Tumors on 68Ga-FAPI-RGD PET-CT and Radioligand Therapy With 177Lu-FAPI-RGD | recruiting | Early Phase 1 | 15 | Peking Union Medical College HospitalOTHER | 1 | Oct 15, 2024 | clinicaltrials |
| NCT06631495 | All-cause and Diseases-specific Mortality of High-risk HPV Infection | not yet recruiting | — | 100,000 | Peking Union Medical College HospitalOTHER | 1 | Oct 8, 2024 | clinicaltrials |
| NCT06613269 | 68Ga-NY104 PET/CT Guided Radiation Therapy in CcRCC.(NYCRRT) | recruiting | Phase 2 | 40 | Peking Union Medical College HospitalOTHER | 1 | Sep 27, 2024 | clinicaltrials |
| NCT06489158 | Observation of Exhaled VOC Biomarkers Characteristics in Admitted Women with Breast Ultrasound BI-RADS 4 Grade | recruiting | — | 168 | Peking Union Medical College HospitalOTHER | 1 | Sep 20, 2024 | clinicaltrials |
| NCT04167657 | SinTilimab After Radiation (STAR Study)(STAR) | completed | Phase 2 | 14 | Peking Union Medical College HospitalOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT05400967 | Diagnosis of Metastatic Tumors on 68Ga-FAPI PET-CT and Radioligand Therapy with 177Lu-EB-FAPI | recruiting | Early Phase 1 | 10 | Peking Union Medical College HospitalOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06573788 | Multidisciplinary Prehabilitation Management Pathway and Network Platform Construction | unknown | N/A | 64 | Peking Union Medical College HospitalOTHER | 0 | Aug 27, 2024 | clinicaltrials |
| NCT04217967 | Ixazomib, Lenalidomide, and Combination for Maintenance in NDMM Patients | completed | Phase 4 | 211 | Peking Union Medical College HospitalOTHER | 1 | Aug 1, 2024 | clinicaltrials |
| NCT06521684 | Translational Study of MSS, TP53 Mutation and Chromosome Instability Relationship in Endometrial Carcinoma | unknown | — | 110 | Peking Union Medical College HospitalOTHER | 0 | Jul 26, 2024 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials